| Online-Ressource |
Verfasst von: | Seitz, Christian [VerfasserIn]  |
| Häcker, Axel [VerfasserIn]  |
Titel: | Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy |
Verf.angabe: | Christian Seitz, Mahesh Desai, Axel Häcker, Oliver W. Hakenberg, Evangelos Liatsikos, Udo Nagele, David Tolley |
Jahr: | 2012 |
Umfang: | 13 S. |
Fussnoten: | Published online ahead of print on September 28, 2011 ; Gesehen am 03.07.2018 |
Titel Quelle: | Enthalten in: European urology |
Ort Quelle: | Amsterdam [u.a.] : Elsevier Science, 1976 |
Jahr Quelle: | 2012 |
Band/Heft Quelle: | 61(2012), 1, Seite 146-158 |
ISSN Quelle: | 1873-7560 |
| 1421-993X |
Abstract: | Context: Incidence, prevention, and management of complications of percutaneous nephrolitholapaxy (PNL) still lack consensus. Objective: To review the pidemiology of complications and their prevention and management. Evidence acquisition: A literature review was performed using the PubMed database between 2001 and May 1, 2011, restricted to human species, adults, and the English language. The Medline search used a strategy including medical subject headings (MeSH) and free-text protocols with the keywords percutaneous, nephrolithotomy, PCNL, PNL, urolithiasis, complications, and Clavien, and the MeSH terms nephrostomy, percutaneous/adverse effects, and intraoperative complications or postoperative complications. Evidence synthesis: Assessing the epidemiology of complications is difficult because definitions of complications and their management still lack consensus. For a reproducible quality assessment, data should be obtained in a standardized manner, allowing for comparison. An approach is the validated Dindo-modified Clavien system, which was originally reported by seven studies. No deviation from the normal postoperative course (Clavien 0) was observed in 76.7% of PNL procedures. Including deviations from the normal postoperative course without the need for pharmacologic treatment or interventions (Clavien 1) would add up to 88.1%. Clavien 2 complications including blood transfusion and parenteral nutrition occurred in 7%; Clavien 3 complications requiring intervention in 4.1.%; Clavien 4, life-threatening complications, in 0.6%; and Clavien 5, mortality, in 0.04%. High-quality data on complication management of rare but potentially debilitating complications are scarce and consist mainly of case reports. Conclusions: Complications after PNL can be kept to a minimum in experienced hands with the development of new techniques and improved technology. A modified procedure-specific Clavien classification should be established that would need to be validated in prospective trials. |
DOI: | doi:10.1016/j.eururo.2011.09.016 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: http://dx.doi.org/10.1016/j.eururo.2011.09.016 |
| Volltext: http://www.sciencedirect.com/science/article/pii/S0302283811010232 |
| DOI: https://doi.org/10.1016/j.eururo.2011.09.016 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Clavien |
| Complication |
| Incidence |
| Management |
| PCNL |
| Percutaneous nephrolitholapaxy |
| PNL |
| Prevention |
| Review |
| Urolithiasis |
K10plus-PPN: | 1577238567 |
Verknüpfungen: | → Zeitschrift |
Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy / Seitz, Christian [VerfasserIn]; 2012 (Online-Ressource)